A study designed to determine the levels of exercise-industry pulmonary hemorrhage in 2-year-olds racing in South Florida is complete, but the data won't be released until a scientific paper is published after peer review.
NTRA Safety and Integrity Alliance calls on tracks to work with their state regulators to make sure testing standards are up to par.
Development of a central rule-making process for uniform medication policies and related implementation will be the 2016 focus for the Association of Racing Commissioners International.
The first phase of an Ohio study into the effects the mineral cobalt has on horses showed that intravenous administration at high doses has detrimental effects on body systems.
The New York State Commission Nov. 23 proposed far-reaching equine drug rules as they slapped trainer Steve Asmussen with a $10,000 fine stemming from a probe into allegations of equine abuse brought against him by PETA.
State officials in Pennsylvania said they expect lawmakers the week of Nov. 16 to consider legislation that would, in part, stabilize the funding of horse racing regulation.
Standardbred racetrack owner Jeff Gural Nov. 12 said track owners should take the lead in improving integrity in the horseracing industry.
The New York State Gaming Commission has indefinitely suspended trainer Roy Sedlacek for two positives in October at Belmont Park for AH-7921, a synthetic opioid.
TOBA Nov. 2 said it will become a member of the Coalition for Horse Racing Integrity and support federal legislation that would allow USADA oversight over equine medication, drug testing, and enforcement.
Breeders' Cup has again expanded its welfare, safety, and integrity protocol for this year's World Championships, with a big assist from host track Keeneland.
The furosemide industry is a $3 million annual business for Thoroughbred racing in New York state, regulators said Oct. 26, with the average horse given $500 worth of doses in a typical year.
The state of New York, citing costs savings, is considering a plan to halt a practice in which the state, at its expense, tests all claimed horses to check for the presence of drugs or other substances.
- By Tom LaMarra
- Horse Health, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky, Mid-Atlantic Region
The RMTC, which met Oct. 13, cited progress in state-by-state adoption of components of the National Uniform Medication Program and also added four drugs to the list of controlled substances.
Six members of Congress have announced their support for the Thoroughbred Horseracing Integrity Act of 2015, according to the Coalition for Horse Racing Integrity.
The California Horse Racing Board Oct. 9 said limits on the amount of the trace element cobalt that can be detected in racehorses officially took effect Oct. 5.
Kent Stirling, who has served as executive director of the Florida Horsemen's Benevolent and Protective Association since 1995, will transition out of the position this year.
A day after prominent trainer Graham Motion questioned the research conducted to determine the threshold level and withdrawal time for methocarbamol (Robaxin), the RMTC defended its efforts.
Keeneland said Oct. 8 it officially is in support of the Thoroughbred Horseracing Integrity Act of 2015 and has joined the Coalition for Horse Racing Integrity, a group that also supports the federal legislation.
The Kentucky Horse Racing Commission has suspended Graham Motion for five days and fined the trainer $500 for a medication overage in Bewitch Stakes (gr. IIIT) winner Kitten's Point. Motion has appealed the ruling.
The chairman of the International Federation of Horseracing Authorities, in an address Oct. 5 in Paris, France, outlined what he called matters that are critical to the future of racing on an international level.
- By BloodHorse Staff
- Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky, Mid-Atlantic Region
ARCI Sept. 29 announced members of a committee that will work with regulators in each racing state to complete implementation of reforms that make up the National Uniform Medication Program.
The New York State Gaming Commission Sept. 24 passed several rule amendments related to equine medication, including further restrictions on the use of non-steroidal anti-inflammatory drugs and a total ban on stanozolol.
In a survey designed to combat claims that the leaders of horsemen's groups don't represent their membership, the Florida HBPA Sept. 16 released the results of a poll that said most respondents support use of Lasix.
The Association of Racing Commissioners International is stepping up efforts to get state regulators to fully adopt the National Uniform Medication Program.
Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15.
The United States Anti-Doping Agency says it acted appropriately when allowing Floyd Mayweather to receive an intravenous injection before his May 2 fight with Manny Pacquiao.
The people who put their money on the line wagering on horse racing would like to see an overhaul of its drug testing and enforcement, based on results of a recent survey.
The Ohio State Racing Commission is moving forward with what it has called a comprehensive study into the effects of the mineral cobalt on racehorses.
The Indiana Horse Racing Commission said Aug. 31 that none of the 221 samples tested for cobalt during the first 60 days of the Indiana Grand Racing & Casino meet were above the published threshold level.
The New York Thoroughbred Horsemen's Association Sept. 1 said it will commit $450,000 to acquire state-of-the-art equipment for the New York Equine Drug Testing and Research Program at Morrisville State College.
The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks.
The Louisiana State Racing Commission Aug. 24 adopted the Controlled Therapeutic Medication Schedule of 26 commonly used substances.
A new study funded by the USTA is designed to determine whether the naturally occurring mineral cobalt, when administered in larger, regular doses, has blood-doping qualities and could enhance performance.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
Use of race-day furosemide will be the topic for a daylong forum put together by the New York State Gaming Commission Aug. 25 in Saratoga Springs, N.Y.
A co-sponsor of federal legislation that would authorize oversight of equine medication and drug-testing said Congress could schedule a committee hearing on the bill this fall. Meanwhile, the debate on the bill continues.
The board of directors of the Thoroughbred Owners and Breeders Association Aug. 12 tackled the issue of whether to support the Thoroughbred Horseracing Integrity Act of 2015.
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
Do horse racing's current medication control programs stand up? read blog
Leroy Gessmann, president of the Iowa Horsemen's Benevolent and Protective Association, was elected president of the National HBPA Aug. 9 when the board of directors met as part of the organization's summer convention.
The Association of Racing Commissioners International the afternoon of Aug. 9 issued a strong response to comments made during The Jockey Club Round Table conference held earlier in the day in Saratoga Springs, N.Y.
State-by-state efforts to bring about uniformity in medication policies and drug testing aren't sufficient to move the Thoroughbred industry forward speakers said Aug. 9 at The Jockey Club Round Table conference.
When the National Horsemen's Benevolent and Protective Association meets Aug. 6-9 for its summer convention, equine medication will again be a major issue for the organization.
A recommendation by an attorney for Delaware racing stewards to drop a therapeutic medication overage case against trainer Todd Pletcher could impact the sport's move toward uniform medication rules, Pletcher's attorney said.
The West Virginia Racing Commission voted July 28 to hire a new equine drug-testing laboratory when the contract with its current lab ends at the end of August.
In an unusual development, Canterbury Park has come to the defense of top trainer McLean Robertson, who was suspended for 90 days and fined $2,000 by the Minnesota Racing Commission for a positive test for a Class 1 drug.
Trainer Tom Amoss and the Indiana Horse Racing Commission have entered into a settlement agreement in a complex case involving a medication positive at Hoosier Park Racing & Casino in 2011.
West Virginia has joined other states in the Mid-Atlantic region in posting an advisory regarding use of two therapeutic drugs that can be problematic for horsemen.
Host Lenny Shulman examines challenges with drug testing labs, reacts to California Chrome's return home, and catches up with Hansen by talking with Dr. Kendall Hansen. Presented by Hill 'n' Dale Stallions watch video
An effort that began in the Mid-Atlantic region more than two years ago has made "significant progress," according to the Racing Medication and Testing Consortium.
Most Popular Stories
- As Arrogate's Stature Builds, So Do Expectations
- Dream It Is The Real Deal in Schuylerville
- Maryland Horse of the Year Ben's Cat Dies
- Classic Empire to Resume Galloping
- John Henry, Phil Marino, and Early Cajun Days
- Sanford Adds Another Chapter to Rich History Saturday
- Litfin: No Going Against Arrogate in San Diego
- CHRB Discusses Cutting Back Racing Dates
- Arrogate Begins Del Mar Journey in San Diego Handicap
- Proctor's Ledge Makes Splash in Lake George